Dow Jones

44 705,53

-0,17%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
International Stem Cell Corporation (QB) (ISCO)
International Stem Cell Corporation (QB) (ISCO) Actualités

ISCO

International Stem Cell (QB) (ISCO)

International Stem Cell Corporation (QB)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ISCO

1 2 3 4 5 6 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
13/11/2024	22h00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ISCO	International Stem Cell Corporation (QB)
13/06/2024	22h05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ISCO	International Stem Cell Corporation (QB)
27/09/2023	18h27	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	USOTC:ISCO	International Stem Cell Corporation (QB)
18/09/2023	14h01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ISCO	International Stem Cell Corporation (QB)
21/06/2023	20h08	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
16/06/2023	23h23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
12/05/2023	22h02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
28/04/2023	22h31	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	USOTC:ISCO	International Stem Cell Corporation (QB)
30/03/2023	22h37	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
27/04/2022	22h32	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ISCO	International Stem Cell Corporation (QB)
27/06/2020	00h07	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:ISCO	International Stem Cell Corporation (QB)
13/05/2020	19h35	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
14/08/2019	23h07	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
29/04/2019	14h30	InvestorsHub NewsWire	International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial	USOTC:ISCO	International Stem Cell Corporation (QB)
16/04/2019	14h30	InvestorsHub NewsWire	International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results	USOTC:ISCO	International Stem Cell Corporation (QB)
07/03/2019	12h05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:ISCO	International Stem Cell Corporation (QB)
13/02/2019	14h30	InvestorsHub NewsWire	International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury	USOTC:ISCO	International Stem Cell Corporation (QB)
15/01/2019	14h30	InvestorsHub NewsWire	International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business	USOTC:ISCO	International Stem Cell Corporation (QB)
05/12/2018	14h30	InvestorsHub NewsWire	International Stem Cell Corporation is Valued at $6.16 per Share by Edison Investment Research	USOTC:ISCO	International Stem Cell Corporation (QB)
15/11/2018	14h30	InvestorsHub NewsWire	International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018	USOTC:ISCO	International Stem Cell Corporation (QB)
05/11/2018	14h30	InvestorsHub NewsWire	International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical Trial	USOTC:ISCO	International Stem Cell Corporation (QB)
30/10/2018	13h30	InvestorsHub NewsWire	International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting	USOTC:ISCO	International Stem Cell Corporation (QB)
08/10/2018	14h30	InvestorsHub NewsWire	International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial	USOTC:ISCO	International Stem Cell Corporation (QB)
02/10/2018	14h00	InvestorsHub NewsWire	International Stem Cell Corporation Raised Funds Through a Private Placement at Premium to Market	USOTC:ISCO	International Stem Cell Corporation (QB)
21/08/2018	13h00	InvestorsHub NewsWire	International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program	USOTC:ISCO	International Stem Cell Corporation (QB)
15/08/2018	13h00	InvestorsHub NewsWire	International Stem Cell Corp Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018	USOTC:ISCO	International Stem Cell Corporation (QB)
15/08/2018	12h49	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:ISCO	International Stem Cell Corporation (QB)
10/07/2018	13h00	InvestorsHub NewsWire	International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products	USOTC:ISCO	International Stem Cell Corporation (QB)
11/06/2018	13h00	InvestorsHub NewsWire	International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial	USOTC:ISCO	International Stem Cell Corporation (QB)
05/06/2018	13h00	InvestorsHub NewsWire	International Stem Cell Corporation to Launch Advanced Joint Supplement	USOTC:ISCO	International Stem Cell Corporation (QB)